Two Sigma Advisers’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,856
Closed -$98.5K 608
2025
Q4
$98.5K Sell
11,856
-19,252
-62% -$207K ﹤0.01% 2226
2025
Q3
$454K Sell
31,108
-7,730
-20% -$92.5K ﹤0.01% 1798
2025
Q2
$437K Sell
38,838
-418,780
-92% -$3.24M ﹤0.01% 1809
2025
Q1
$2.61M Sell
457,618
-283,500
-38% -$2.89M 0.01% 1049
2024
Q4
$7.28M Sell
741,118
-66,100
-8% -$567K 0.02% 574
2024
Q3
$6.58M Buy
807,218
+21,129
+3% +$212K 0.02% 619
2024
Q2
$10.5M Buy
786,089
+757,813
+2,680% +$22.6M 0.02% 524
2024
Q1
$1.31M Buy
28,276
+9,452
+50% +$489K ﹤0.01% 1443
2023
Q4
$1.27M Buy
18,824
+14,705
+357% +$900K ﹤0.01% 1525
2023
Q3
$298K Sell
4,119
-1,870
-31% -$150K ﹤0.01% 1980
2023
Q2
$446K Buy
5,989
+533
+10% +$31.6K ﹤0.01% 1852
2023
Q1
$290K Buy
5,456
+3,477
+176% +$220K ﹤0.01% 2148
2022
Q4
$134K Buy
+1,979
New +$182K ﹤0.01% 2255

Other funds holding DNA